Hence, research on both valid and cost effective medications for the immunosuppressive treatment of IMN is ingoing, particularly in developing countries.
KnowMyMeds enables healthcare practitioners to perform clinically validated, cost-effective medication review for high-risk patients, including "dual eligibles" and the chronically ill, to reduce their drug-related hospitalizations and re-admissions.
While opioid analgesics such as morphine are a cost-effective medication for treatment of moderate to severe pain related to cancer, HIV/AIDS, surgery, and other conditions, they are not adequately available in most developing countries.
Currently, bevacizumab is the most cost-effective medication 16 18 for control of wet AMD compared with ranibizumab (40 times cheaper 5) or aflibercept.
Although the effects of statins on NO bioavailability are multiple, the results of the present study do show that simvastatin, which is a safe and cost-effective medication, can modulate AMPK- and eNOS-dependent arterial function even in the absence of endothelial dysfunction.
Inequities exist in the availability and consistency of supply of established cost-effective medications for RMDs, including non-steroidal anti-inflammatory drugs (NSAIDs; such as ibuprofen, naproxen and diclofenac) and sDMARDs, such as hydroxychloroquine, sulfasalazine, methotrexate (MTX) and leflunomide.
However, our findings concur with previous reviews in managed care and other settings that these interventions may also be associated with undesirable effects such as increased rates of switching to other medications or discontinuation of essential and cost-effective medications [ 3, 48, 82, 83].
In the recent cost-effectiveness analysis based on the MTA data [ 52], behavioural treatment was found to be more cost effective than intensive medication management (mainly stimulants) in ADHD children with co-morbid conditions whereas the opposite was true in pure ADHD children (i.e. no co-morbid conditions).
Kippi Fagerlund poignantly exemplifies how third-party payers relentlessly limit treatment options to those seen as quickly "cost effective," such as brief medication management visits rather than psychotherapeutic approaches.
These analyses show that in spite of higher initial development costs than for clinician-delivered interventions, a computer-delivered intervention may be a cost effective strategy for improving medication adherence in persons treated for HIV.
The emergence of TWG therapy has actually reduced the heavy medical burden, because this medication is cost effective than other immunosuppressive remedies such as TAC, cyclosporine, and leflunomide, particularly for patients in developing countries.
